ImmunityBio converts from Immunomedics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunityBio converts from Immunomedics

IBRX 2.110

-1.4%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jargonweary who wrote (992)	5/5/2025 12:33:33 PM
From: Maturin	Read Replies (1) of 1229

Obviously the company was working their response all weekend long given they received communication from the FDA on May 2nd. Notable that the consultant hired by IBRX is quoted in the release with some strong words for the FDA's decision. My two cents: all of this smacks of egos and reputations at this point, which isn't good for patients or shareholders.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next